Comphya developing an active implantable medical device to restore the erectile function of patient non-responsive to oral drugs.
Comphya has raised $4.0M in total funding. The most recent round was Series A. The last funding was announced in July 2025.
Comphya's investors include Innomedical Technology, Verve Ventures, Zürcher Kantonal Bank, Venture Kick, Praxis Spinal Cord Institute..
Comphya is headquartered in Lausanne, Switzerland.
Comphya developing an active implantable medical device to restore the erectile function of patient non-responsive to oral drugs.
Comphya is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Comphya — Funding & Investors." VCBacked, July 8, 2025, https://www.vcbacked.co/company/comphya. Accessed September 6, 2026.
VCBacked. (2025). Comphya — Funding & Investors. Retrieved September 6, 2026, from https://www.vcbacked.co/company/comphya
{{cite web |title=Comphya — Funding & Investors |url=https://www.vcbacked.co/company/comphya |website=VCBacked |access-date=September 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated